Merck, one of the world’s largest drugmakers, agreed to buy Seattle-based biotechnology company Immune Design for $300 million in…
sciencecityFebruary 25, 2019
Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act…
sciencecityFebruary 22, 2019
Most cancer clinical trials don't meet their enrollment targets and it has been previously thought…
sciencecityFebruary 21, 2019
Anti-HIV broadly neutralizing antibodies (bnAbs) have revealed vaccine targets on the virus’s envelope (Env) protein…
sciencecityFebruary 21, 2019
If you slip on a virtual reality headset to play the Allen Institute for Cell…
sciencecityFebruary 21, 2019
Fred Hutchinson Cancer Research Center investigator Dr. Harmit Malikhas been elected a fellow of the American…
sciencecityFebruary 20, 2019
According to a new study published recently in JAMA, many patients eschew using the safest antibiotic in…
sciencecityFebruary 20, 2019
That is how ISB microbiome researcher Dr. Sean Gibbons kicked off a recent Facebook Live Q&A.…
sciencecityFebruary 19, 2019
